Skip to content

Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

  • Home
  • Visit our other Journals
    • VJHemOnc
    • VJNeurology
    • VJDementia
    • VJRegenmed
    • VJHemOnc-E
  • About
    • Supporter
    • Partnerships
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjhemonc logo
VJOncology
Logo
  • Diseases
    Genitourinary
    Lung
    Breast
    Head and Neck
    Gastrointestinal
    Skin
    Gynecological
    Brain Tumor
    Sarcoma
    View all Diseases
  • Topics
    CAR-T & Cellular Therapy
    Molecular Profiling
    Nursing
    Radiotherapy
    Policy
    Screening
    Immuno-Oncology
    Surgery
    Real-World Data
    View all Topics
  • Conferences
  • Features
  • VJSessions
  • Podcasts
    • About
      • Supporter
      • Partnerships
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

TAILORx

TAILORx: an update incl 12-year event rates in woman with ER+ lymph node-negative breast cancer 5:18
TAILORx: an update incl 12-year event rates in woman with ER+ lymph node-negative breast cancer
Joseph Sparano • 7 Dec 2022
Racial disparities in breast cancer and metastasis and possible contributing biological factors 4:39
Racial disparities in breast cancer and metastasis and possible contributing biological factors
Joseph Sparano • 7 Dec 2022
Molecular profiling in early breast cancer 8:22
Molecular profiling in early breast cancer
Christos Sotiriou • 10 May 2021
Should chemotherapy be used in post-menopausal patients with low genomic risk HR+ breast cancer? 3:23
Should chemotherapy be used in post-menopausal patients with low genomic risk HR+ breast cancer?
Hope Rugo • 26 Mar 2021
Systemic therapy at the St Gallen Consensus: multi-gene testing, Ki67, and oligometastatic disease 16:13
Systemic therapy at the St Gallen Consensus: multi-gene testing, Ki67, and oligometastatic disease
Beat Thürlimann et al. • 22 Mar 2021
Time for change: introducing genomic predictors in ER+ breast cancer 3:11
Time for change: introducing genomic predictors in ER+ breast cancer
Martine Piccart • 23 Mar 2021
Genomic predictors for treatment selection in ER+ breast cancer: TAILORx, MINDACT, and RxPONDER 4:13
Genomic predictors for treatment selection in ER+ breast cancer: TAILORx, MINDACT, and RxPONDER
Martine Piccart • 23 Mar 2021
SABCS 2020: monarchE, PENELOPE-B, TAILORx & ASCENT 2:16
SABCS 2020: monarchE, PENELOPE-B, TAILORx & ASCENT
Matteo Lambertini • 9 Dec 2020
Trial updates in breast cancer from ASCO: TAILORx, PAKT, MONARCH 2 & MONALEESA-3 2:45
Trial updates in breast cancer from ASCO: TAILORx, PAKT, MONARCH 2 & MONALEESA-3
Robert Coleman • 1 Jun 2018
Breast cancer: new advances in personalized medicine and therapeutics 3:13
Breast cancer: new advances in personalized medicine and therapeutics
Howard Burris • 1 Jun 2018
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • VJ Sessions
  • Features
  • Podcasts
Newsletter

Receive the latest news and videos from VJOncology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJOncology logo
The content of VJOncology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy